Details for Case No.4773152
| Details for Case No. 4773152 | |||
|---|---|---|---|
| Defendant | Lab 21 Healthcare Limited | ||
| Description | 1. Failure to notify HSE of its (deliberate) use of HG2 and HG3 biological agents at least 20 days in advance of doing so. 2. Failure to ensure that plant and equipment (including the CL3 extract system and MSCs; employed as control measures to meet the requirements of Regulation 7) were maintained in an efficient state, efficient working order, and in good repair. 3. Failure to ensure thorough examination and testing of engineering controls (namely the CL3 extract system and MSCs (employed as LEV to meet the requirements of Regulation 7) at least once in the preceding 14 months. 4. Failure to ensure that the CL3 laboratory was sealable for disinfection (by gaseous fumigation relied upon as means of effective decontamination in the event of spillage of HG3 biological agents beyond primary containment). | ||
| Offence Date | 28/06/2018 | ||
| Total Fine | £52,000.00 | Total Costs Awarded to HSE | £26,000.00 |
|
Breaches involved in this Case |
|||
| Location of Offence | |||
| Address | Axminster/Lab 21 Healthcare Li Lab 21 Healthcare Limited Unit 5 Weycroft Avenue AXMINSTER Devon EX13 5HU England |
Region | Wales & South West |
| Local Authority | East Devon | ||
| Industry | Manufacturing | ||
| Main Activity | 21200 - MF PHARMACEUTICAL PREPARATIONS | ||
| Type of Location | Fixed | ||
| HSE Details | |||
| HSE Group | CEMHDU8HUS | HSE Directorate | Chemical Explo & Microbio Hazards Division |
| HSE Area | HSE Division | South West | |